Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Apr;9(4):936-939.
doi: 10.21037/jtd.2017.03.10.

Investigating the long-term legacy of statin therapy

Affiliations
Editorial

Investigating the long-term legacy of statin therapy

Kohei Takata et al. J Thorac Dis. 2017 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: SJ Nicholls reports having received research support from Anthera, AstraZeneca, Amgen, Cerenis, Eli Lilly, Novartis, Resverlogix and Sanofi-Regeneron and is a consultant for AstraZeneca, Amgen, Boehringer Ingelehim, CSL Behring, Cerenis, Eli Lilly, Kowa, Merck, Novartis, Pfizer, Resverlogix, Roche, Sanofi-Regeneron and Takeda. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7. 10.1056/NEJM199511163332001 - DOI - PubMed
    1. Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 2007;357:1477-86. 10.1056/NEJMoa065994 - DOI - PubMed
    1. Ford I, Murray H, McCowan C, et al. Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study. Circulation 2016;133:1073-80. 10.1161/CIRCULATIONAHA.115.019014 - DOI - PMC - PubMed
    1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9. - PubMed
    1. Sever PS, Chang CL, Gupta AK, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K. Eur Heart J 2011;32:2525-32. 10.1093/eurheartj/ehr333 - DOI - PubMed

LinkOut - more resources